USANA Health Sciences Reports Record Results for Second Quarter 2018; Increases 2018 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
USANA Health Sciences Inc. (USNA) PT Raised to $135 at Pivotal Research Amid 'Blow-Out' Qtr
July 25, 2018 2:17 PM EDTPivotal Research raised its price target on USANA Health Sciences Inc. (NYSE: USNA) to $135.00 (from $100.00) while maintaining a Hold rating following 'blow-out' results and higher guidance.
Analyst Timothy Ramey noted sales were positive in every geography even the perennially-flat Americas & Europe region posted a... More
USANA Health Sciences (USNA) Tops Q2 EPS by 23c, Revenues Beat; Boosts FY18 EPS/Revenues Outlook
July 24, 2018 4:35 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.36, $0.23 better than the analyst estimate of $1.13. Revenue for the quarter came in at $301.5 million versus the consensus estimate of $284.54 million.
Our operating results for the second quarter exceeded our expectations and reflect the momentum we are seeing in most of our regions. This momentum helped us generate the highest quarterly revenue and earnings per share in the Companys history, said Kevin Guest, Chief Executive Officer. Although the... More

